NCT02429206View on ClinicalTrials.gov

Safety and Efficacy of SQIN™ on Xerosis in Adults With Mobility Problems and Paralysis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Xerosis
Interventions
OTHER

SQIN

Each patient will be asked to self-apply both creams (experimental vs positive control) on the right and left sides of their body (sides will be randomly assigned).

OTHER

standard moisturizing cream (Glaxal Base)

Trial Locations (1)

G1Y2T4

Nordic Life Science Pipeline, Québec

All Listed Sponsors
lead

Nordic Life Science Pipeline Inc.

OTHER

NCT02429206 - Safety and Efficacy of SQIN™ on Xerosis in Adults With Mobility Problems and Paralysis | Biotech Hunter | Biotech Hunter